Volume was never
the problem.

The Distinction

Descent and deflation are different complaints.

Put a hand under the breast and lift it two centimetres. If what you see in the mirror is what you came here for, you need a lift. If the breast still looks empty in the upper pole once it is held up, you need volume as well — and possibly instead.

That crude test is close to the whole diagnosis, and it is worth doing before you read any further, because it determines which of two very different operations this conversation is about. An implant placed into a breast whose nipple has descended will make the breast larger and lower. It fills the lower pole, pushes the nipple further down the curve, and produces the shape surgeons call a waterfall — the device sitting high and firm, the gland sliding off the front of it. It is one of the more difficult results to correct, and it is entirely predictable from the pre-operative examination.

Assessment

How descent is actually graded.

The classification in use since 1976 is Regnault’s, and it turns on one landmark: where the nipple sits relative to the inframammary fold — the crease under the breast. Not where the breast sits. Where the nipple sits.

Two measurements are taken alongside it. The sternal-notch-to-nipple distance, which tells you how far the nipple has to travel and therefore how long the pedicle must be; in one series a distance over 26 cm was the threshold at which secondary nipple correction became substantially more likely. And the nipple-to-fold distance, which sets the length of the lower pole you are about to build and is the single number most closely tied to bottoming out later.

The Scar

What the pattern buys, and what it costs.

Every lift trades skin for shape. The pattern is not a style preference — it is arithmetic. The further the nipple must rise and the more envelope there is to remove, the longer the scar has to be, and no technique escapes that. What follows is what each pattern can actually do.

The fees are not a menu to choose from. The pattern follows from how far the nipple must travel and how much envelope has to go, and the fee follows from the pattern — which is why a surgeon offering you the cheaper scar is usually offering you the smaller correction. A caution about all technique comparisons in this field: the randomised evidence comparing vertical against inverted-T comes from breast reduction, not from mastopexy. In the largest of those trials, 255 patients randomised and followed for a year, there was no difference between the two techniques in any quality-of-life measure. A meta-analysis found fewer overall complications and less wound dehiscence with the vertical pattern, and no difference in seroma, haematoma, nipple necrosis, fat necrosis or reoperation. There is no equivalent randomised trial in mastopexy at all.

The Pedicle

The part of the operation you never see.

The nipple is not detached and moved. It travels attached to a tongue of breast tissue that carries its blood supply and its nerves — the pedicle. Which direction that tongue comes from is the decision that governs nipple survival, nipple sensation, and where the remaining volume ends up sitting.

• Superomedial. The pedicle enters from above and towards the sternum. It brings volume with it into the upper inner quadrant — the part of the breast that reads as fullness in clothing — and it shortens the operation.
• Inferior. The pedicle rises from the fold. Reliable, familiar, and it leaves more tissue in the lower pole, which is exactly the tissue that later stretches.
• Central and superior variants. Chosen where the parenchyma is distributed unusually, or in revision, where the previous operation has already decided what blood supply remains.

Two meta-analyses have compared the superomedial and inferior pedicles across thousands of breasts, and they disagree with each other on the point patients care about most. One, pooling 5,123 breasts, found the superomedial pedicle gave higher satisfaction scores and less infection but a significantly higher rate of decreased nipple sensation (relative risk 1.50). The other, pooling twelve comparative studies, found fewer overall complications with superomedial and no significant difference at all in nipple sensation, nipple necrosis, dehiscence, seroma, haematoma or reoperation. Both are recent, both are competently done, and both cannot be right.

The honest summary is the one a 2014 systematic review of nerve injury in aesthetic breast surgery reached: after augmentation, some alteration in sensation occurs in roughly 13 to 15 per cent of patients, and the data were insufficient to determine the rate in mastopexy at all. Nobody can quote you a mastopexy-specific figure, because nobody has measured it properly.

The Central Decision

One operation, or two.

If you want to be lifted and you also want to be larger, there are two ways to get there. Do both in one anaesthetic, or lift first and add volume at a second operation months later. This is the most consequential choice on the page, and it is worth understanding why it is contested rather than being told which one is correct.

The two halves of the operation pull against each other. A lift tightens the skin envelope and reduces its dimensions. An implant expands what is inside that envelope. Doing both at once means removing exactly the right amount of skin around a volume that has just changed, on tissue whose blood supply has just been rearranged, with swelling under way. It can be done well and is done well every day. It is simply a harder problem than either operation alone, and the published numbers reflect that.

The argument made for doing it in one stage is usually framed as follows: a one-stage operation with a 16 per cent revision rate is better than a staged plan with a 100 per cent second-operation rate. That is a real argument and it is stated in the literature in almost those words. It is also rhetorically slippery, and you should see why. A planned second stage is not a complication. It is a shorter, cheaper, lower-risk operation performed on healed tissue at a time of your choosing, quoted in advance. A revision is an unplanned operation performed because something did not work. Counting them as the same event flatters the single-stage figure.

The argument the other way is equally incomplete. Staging costs you a second anaesthetic, a second recovery and, if you are travelling from abroad, a second trip — which is not a small thing when the trip is to Japan.

The position taken here is that staging is not a failure of nerve, it is a tool — used where the skin is thin or already stretched, where the nipple has a long way to travel, where a previous operation has already used up the tissue’s tolerance, or where the volume you want is large enough that the envelope cannot be judged reliably in one sitting. Where those do not apply, one operation is reasonable and is offered.

Durability

What happens in the years afterwards.

A lift is not permanent, and it is worth being precise about what that means rather than leaving it as a disclaimer. Skin that has stretched once has demonstrated its tendency. Gravity does not stop. What surgery buys is a reset of position and a reshaping of the parenchyma; what it cannot buy is different tissue.

• Recurrent ptosis is the commonest single complication of the combined operation, pooled at 5.2 per cent — but pooled from studies mostly followed for less than a year, which is less than the minimum needed to detect it. One comparative study states the point explicitly: a minimum of twelve months is required before bottoming out can be assessed at all.
• Bottoming out is measurable. In the best objective study retrieved — 72 patients measured by three-dimensional imaging — the lower-pole arch elongated by 8.04 per cent at one year and 9.44 per cent at three years, with significantly more stretch where the implant exceeded 400 cc. The trajectory flattens after the first year, but it does not reverse.
• Implant size is a durability decision, not only an aesthetic one. The larger the device, the more load on a lower pole you have just rebuilt.
• Revisions cluster earlier than people expect. In a review of 134 consecutive revision cases, the mean interval to reoperation was 8.9 years after augmentation alone but 4.3 years after mastopexy-augmentation, and in that group 90 per cent of revisions were attributed to natural progression rather than to a complication.
• Internal support does not solve it. Mesh and scaffolds are marketed as an internal bra. A systematic review of that literature concluded that meshes do not effectively prevent recurrent ptosis and bottoming out and may not be superior to well-executed suture techniques; a second review of 31 studies and 2,425 patients concluded the evidence is insufficient to recommend routine use. A resorbable scaffold has pooled data from only three studies, with a confidence interval for delayed wound healing running from 0.3 to 16.6 per cent. That is not a reason never to use one. It is a reason not to be sold one.

Candidacy

Who it suits, and who it does not.

• It suits you if the nipple has descended to or below the fold and holding the breast up produces the shape you want.
• It suits you if the areola has stretched, which is corrected as part of every pattern rather than as an extra.
• It suits you after weight loss or pregnancy once weight has been stable for six months or more. Not before. An operation planned around an envelope that is still changing will be planned around the wrong envelope.
• It is a poor idea if you are planning a pregnancy soon. Pregnancy changes breast volume and skin in both directions, and there is no published data on whether a subsequent pregnancy undoes a lift. We would rather say that than guess.
• Smoking is a genuine contraindication here, more than in most of what is done at this practice. The pedicle carrying your nipple depends on small vessels. A large database found smoking increased infection risk across aesthetic surgery generally; a large single-centre augmentation-mastopexy series found smokers had 26.1 per cent complications against a baseline of 15.3.
• After major weight loss the operation is different in kind, not degree: thinner tissue, a much larger envelope, a longer pattern, and a higher rate of delayed healing. It is offered, and it is quoted and consented differently.
• If your objection is upper-pole emptiness only, and the nipple is well positioned, you may not need this operation at all. That is worth hearing before you travel.

The Operation

What actually happens.

1. Marking, standingThe entire plan is drawn with you upright, because a breast marked lying flat is marked in the one position nobody will ever see it in. New nipple position, pattern, and the existing asymmetry — present in almost everyone, easier to discuss before surgery than to explain after it.
2. The pedicle is designed firstBefore any skin is removed. Its width, direction and thickness are decided from how far the nipple must travel and from what the parenchyma is actually made of, which is assessed by hand rather than assumed from the photographs.
3. De-epithelialisationThe surface layer of skin within the pattern is removed while the dermis beneath it is kept. That retained dermis is what carries the nipple safely and what the new shape is built on.
4. Parenchymal reshapingThe gland is not simply lifted inside a tighter bag. It is mobilised, redistributed towards the upper pole and fixed. This is the step that decides how long the result lasts, because skin alone will not hold a breast up — and it is the step that is skipped when a lift is done quickly.
5. Volume, where volume is being addedAn implant into a pocket dissected to planned dimensions, or fat placed in fine passes across planes. Where an implant is used, the envelope is closed provisionally around it and reassessed before anything is trimmed definitively.
6. Sitting you upSymmetry, nipple height and lower-pole length are judged with you upright on the table, before final closure. Skin is removed last and conservatively; it is far easier to take a little more than to give any back.
7. Closure and supportLayered closure with attention to the junction at the base of the vertical limb, which is where delayed healing concentrates. Support garment applied before you leave theatre.

Recovery

Two weeks in Japan, a year to the final shape.

• Week one. Soreness rather than sharp pain, swelling, and a shape that sits too high and looks too round. That is the intention. A lift that looks correct on day three will look wrong at month six.
• Weeks two to six. Most patients fly home in this window, after in-person review and clearance to travel. Support garment continuously. No upper-body loading, no lifting overhead, no sleeping face down.
• Months two to four. The lower pole relaxes and the breast begins to look like the plan rather than like surgery. Scars are at their most active and most red during this period; they are not yet what they will be.
• Six months. Shape is broadly established. Where fat was used, this is when the surviving volume is judged.
• Twelve months. The point at which the result is genuinely assessable and, if anything is to be revised, the earliest sensible time to consider it. Scars continue to fade for eighteen months or longer.

Evidence

What the published data shows.

The least flattering figures are included deliberately. Where two studies contradict each other, both are shown.

These figures describe published study populations authored by others. They do not describe results at this practice and are not a prediction of your individual outcome. Full citations are listed at the foot of this page.

Fees

What it costs.

A lift is priced by pattern, because a periareolar correction and an inverted-T lift are not the same operation and should not carry the same fee. Which one applies to you is decided by the measurements described above, not by budget. Where a lift is combined with augmentation, both are charged and your written quotation states the total.

All figures are standard prices, not monitor prices, current as of August 2026 and subject to change. Your written quotation is the binding figure and is issued before you book travel. See the full fee schedule and process for international patients.

Guarantee

Covered, with one honest limit.

Mastopexy carries the one-year guarantee, in all three patterns. It covers re-examination by your operating surgeon at no consultation charge, post-operative treatment, and adjustment where you wish it and the operating surgeon judges it appropriate. Where a lift is combined with Condense Rich fat transfer augmentation, both components are covered; where it is combined with an implant, the implant is not, and is subject instead to the manufacturer’s own warranty terms for the specific device.

The limit worth stating plainly is what a guarantee can and cannot be about. It covers the operation. It does not cover the passage of time. Skin that stretched once will continue to behave like skin that stretched once, and gradual settling of the lower pole over years is a property of your tissue rather than a defect in the surgery. What the guarantee gives you is a year in which your surgeon remains responsible for the result of the operation itself.

Being outside Japan does not void the guarantee, but making use of it means returning to Japan. Please plan on that basis.

Risks

What can go wrong.

This is elective surgery, it is not covered by health insurance in Japan, and its outcome cannot be guaranteed.

• Scarring. Every pattern leaves a permanent scar. Scars may widen, thicken, become hypertrophic or keloid, or heal at different rates on the two sides. This is the commonest reason patients are dissatisfied with an otherwise good result.
• Delayed wound healing and dehiscence, concentrated at the junction of the vertical limb with the fold, and more likely in smokers, in diabetes, in higher body mass index and after major weight loss.
• Altered or lost nipple sensation, which may be permanent. No reliable mastopexy-specific rate exists in the literature.
• Partial or complete loss of the nipple-areola complex. Rare, and the reason the pedicle is designed before anything is cut. Rates from large-reduction series — 1.7 per cent complete and 5.9 per cent partial — describe far larger operations than a routine lift and should not be read as your risk.
• Areolar widening, non-circularity and pleating, particularly with a periareolar pattern.
• Asymmetry of breast volume, shape, nipple height or areolar diameter. Some asymmetry is present before surgery in almost everyone and is reduced rather than abolished.
• Recurrent ptosis and bottoming out over months to years, more likely with a heavy breast, thin skin, weight change and larger implants.
• A nipple placed too high, which is one of the few genuinely difficult mastopexy outcomes to correct. It is the reason skin is removed conservatively and last.
• Haematoma, seroma, infection and the complications of general anaesthesia.
• Fat necrosis and palpable firmness within the reshaped parenchyma, and, where fat is grafted, oil cyst and calcification.
• Where an implant is used, every implant-specific consideration applies in addition — capsular contracture, rupture, malposition, rippling, late seroma, the associated malignancies and the need for further surgery. These are set out with figures on the Breast Augmentation page.
• Reduced ability to breastfeed. In the best available comparative study, breastfeeding success after reduction or mastopexy was 41 per cent against 82 per cent in women who had been pregnant before surgery.
• Effect on future screening. A lift changes the internal architecture of the breast and its appearance on imaging. Screening remains necessary on the schedule appropriate to your age, and whoever reads it must be told what you have had.
• Travel-related risk. Long-haul flight too soon after surgery carries risk, particularly of venous thromboembolism. Clearance to fly is a clinical judgement made at the time, not a date agreed in advance.

Questions

Frequently asked.

References

Selected literature.

Retrieved from PubMed. The figures quoted above come from these studies, which describe study populations authored by others rather than results at this practice.

1. Regnault P. Breast ptosis. Definition and treatment. Clin Plast Surg. 1976;3(2):193–203. PMID:1261176
2. Eyck BM, van Dongen JA, Athanassopoulos T, et al. The Rainbow Scale for Assessing Breast Ptosis: Validation of Three Different Views. Aesthet Surg J. 2016;36(9):1010–1016. doi:10.1093/asj/sjw129
3. Rinker B, Veneracion M, Walsh CP. Breast ptosis: causes and cure. Ann Plast Surg. 2010;64(5):579–584. doi:10.1097/SAP.0b013e3181c39377
4. Khavanin N, Jordan SW, Rambachan A, Kim JYS. A systematic review of single-stage augmentation-mastopexy. Plast Reconstr Surg. 2014;134(5):922–931. doi:10.1097/PRS.0000000000000582
5. Calobrace MB, Herdt DR, Cothron KJ. Simultaneous augmentation/mastopexy: a retrospective 5-year review of 332 consecutive cases. Plast Reconstr Surg. 2013;131(1):145–156. doi:10.1097/PRS.0b013e318272bf86
6. Messa CA, Messa CA. One-Stage Augmentation Mastopexy: A Retrospective Ten-Year Review of 2183 Consecutive Procedures. Aesthet Surg J. 2019;39(12):1352–1367. doi:10.1093/asj/sjz143
7. Stevens WG, Macias LH, Spring M, Stoker DA, Chacón CO, Eberlin SA. One-Stage Augmentation Mastopexy: A Review of 1192 Simultaneous Breast Augmentation and Mastopexy Procedures in 615 Consecutive Patients. Aesthet Surg J. 2014;34(5):723–732. doi:10.1177/1090820X14531434
8. Stevens WG, Freeman ME, Stoker DA, Quardt SM, Cohen R, Hirsch EM. One-stage mastopexy with breast augmentation: a review of 321 patients. Plast Reconstr Surg. 2007;120(6):1674–1679. doi:10.1097/01.prs.0000282726.29350.ba
9. Spear SL, Dayan JH, Clemens MW. Augmentation mastopexy. Clin Plast Surg. 2009;36(1):105–115. doi:10.1016/j.cps.2008.08.006
10. Lombardo GAG, Gulino M, Marchica P, et al. Septum-Based Augmentation Mastopexy for Moderate to Severe Ptosis in Medium to Large Breasts. Plast Reconstr Surg. 2026;158(2):239e–248e. doi:10.1097/PRS.0000000000012779
11. Prado Filho FSA, Canas C, Camahji MF, et al. Augmentation Mastopexy — Antigravity Flap Technique. Aesthetic Plast Surg. 2025;49(23):6497–6514. doi:10.1007/s00266-025-04805-z
12. Gupta V, Yeslev M, Winocour J, et al. Aesthetic Breast Surgery and Concomitant Procedures: Incidence and Risk Factors for Major Complications in 73,608 Cases. Aesthet Surg J. 2017;37(5):515–527. doi:10.1093/asj/sjw238
13. Hanwright PJ, Hirsch EM, Seth AK, et al. A multi-institutional perspective of complication rates for elective nonreconstructive breast surgery: an analysis of NSQIP data from 2006 to 2010. Aesthet Surg J. 2013;33(3):378–386. doi:10.1177/1090820X13478819
14. Tanas Y, Tanas J. Comparative Outcomes of Superomedial and Inferior Pedicles in Breast Reduction and Mastopexy: A Meta-Analysis of 5123 Breasts. Aesthetic Plast Surg. 2025;49(5):1327–1339. doi:10.1007/s00266-024-04389-0
15. Cang ZQ, Zhang Y, Mu SQ, et al. Complications of Superomedial Versus Inferior Pedicle Reduction Mammaplasty: A Systematic Review and Meta-Analysis. Aesthetic Plast Surg. 2025;49(1):184–197. doi:10.1007/s00266-024-04201-z
16. Ducic I, Zakaria HM, Felder JM, Fantus S. Nerve Injuries in Aesthetic Breast Surgery: Systematic Review and Treatment Options. Aesthet Surg J. 2014;34(6):841–856. doi:10.1177/1090820X14536726
17. Araco A, Araco F, Sorge R, Gravante G. Sensitivity of the nipple-areola complex and areolar pain following aesthetic breast augmentation in a retrospective series of 1200 patients: periareolar versus submammary incision. Plast Reconstr Surg. 2011;128(4):984–989. doi:10.1097/PRS.0b013e3182268d73
18. Thoma A, Ignacy TA, Duku EK, et al. Randomized controlled trial comparing health-related quality of life in patients undergoing vertical scar versus inverted T-shaped reduction mammaplasty. Plast Reconstr Surg. 2013;132(1):48e–60e. doi:10.1097/PRS.0b013e3182910cb0
19. Li Z, Qian B, Wang Z, et al. Vertical Scar Versus Inverted-T Scar Reduction Mammaplasty: A Meta-Analysis and Systematic Review. Aesthetic Plast Surg. 2021;45(4):1385–1396. doi:10.1007/s00266-021-02167-w
20. Swanson E. A Comparison of 28 Published Augmentation/Mastopexy Techniques Using Photographic Measurements. Plast Reconstr Surg Glob Open. 2020;8(9):e3092. doi:10.1097/GOX.0000000000003092
21. Atiyeh B, Ghieh F, Chahine F, Oneisi A. Ptosis and Bottoming out Following Mastopexy and Reduction Mammoplasty. Is Synthetic Mesh Internal Breast Support the Solution? A Systematic Review. Aesthetic Plast Surg. 2022;46(1):25–34. doi:10.1007/s00266-021-02398-x
22. Wong GH, Hamilton S. A systematic review of mesh support of the breast in aesthetic breast surgery. JPRAS Open. 2025;45:185–198. doi:10.1016/j.jpra.2025.06.001
23. Milani-Reis A, Oliveira JA, Eskandar K, et al. The Use of Poly-4-Hydroxybutyrate (P4HB) Scaffold in Cosmetic Breast Surgery: A Systematic Review and Meta-Analysis. Aesthetic Plast Surg. 2026;50(3):1181–1189. doi:10.1007/s00266-025-05306-9
24. Bistoni G, Sofo F, Cagli B, Buccheri EM, Mallucci P. Artificial Intelligence, Genuine Outcome: Analysis of 72 Consecutive Cases of Subfascial Augmentation Mastopexy With Smooth Round Implants Supported by P4HB Scaffold. Aesthet Surg J. 2024;44(11):1154–1166. doi:10.1093/asj/sjae109
25. Duran A, Eroglu S. Comparative Analysis of Lower Island Flap Transposition (LIFT) in Wise-Pattern Mastopexy. Aesthetic Plast Surg. 2024;48(17):3331–3339. doi:10.1007/s00266-024-03858-w
26. Grewal NS, Fisher J. Why do patients seek revisionary breast surgery? Aesthet Surg J. 2013;33(2):237–244. doi:10.1177/1090820X12472693
27. Lonie S, Karagiannis P, Tavakoli K. FAM — Fat Augmentation Mastopexy: A Method to Avoid Implants. Aesthetic Plast Surg. 2024;48(18):3637–3645. doi:10.1007/s00266-024-03895-5
28. Faure C, Sidahmed-Mezi M, Ferrero L, et al. Successful breastfeeding after breast reduction surgery or mastopexy: A retrospective comparative study. Ann Chir Plast Esthet. 2024;69(4):307–314. doi:10.1016/j.anplas.2024.05.004
29. Zelko I, DeLeonibus A, Haidar J, et al. Nipple-Sparing Gigantomastia Breast Reduction: A Systematic Review. Ann Plast Surg. 2023;90(3):267–272. doi:10.1097/SAP.0000000000003415
30. Stack ER, Garfinkle J, Burns EN, et al. Lifting the Standards: A Systematic Review of Aesthetic Scarless Breast Surgery. Cureus. 2026;18(5):e109131. doi:10.7759/cureus.109131
31. Weale R, Javed MU. Management of High-Riding Nipple-Areola Complex: A Systematic Review of Its Prevention and Management. Aesthetic Plast Surg. 2026;50(3):1025–1043. doi:10.1007/s00266-025-05130-1
32. Kaoutzanis C, Winocour J, Gupta V, et al. The Effect of Smoking in the Cosmetic Surgery Population: Analysis of 129,007 Patients. Aesthet Surg J. 2019;39(1):109–119. doi:10.1093/asj/sjy088
33. Vindigni V, Scarpa C, Tommasini A, et al. Breast Reshaping Following Bariatric Surgery. Obes Surg. 2015;25(9):1735–1740. doi:10.1007/s11695-015-1613-y
34. Tunå Butt S, Widmark-Jensen E, Meyer S, Hansson E. Swedish Normative Scores for the BREAST-Q Reduction/Mastopexy Module. Aesthetic Plast Surg. 2023;47(1):73–80. doi:10.1007/s00266-022-03025-z

Next

Find out whether it is one operation or two.

The consultation is held online, in English, before you commit to any travel. You will be told which pattern your measurements require, whether volume should be added in the same operation or deferred, and what each of those costs — including, where it applies, that what you have in mind is not achievable in a single trip.